Hydrocortisone, vitamin C, thiamine and fludrocortisone (sepsis cocktail) for adults with severe sepsis and septic shock: Open-label randomized controlled trial

Authors

  • Parinya Ruenwilai Department of Internal Medicine, Lamphun Hospital

Keywords:

sepsis cocktail, severe sepsis, septic shock

Abstract

Abstract
Sepsis is a global burden and has a high morbidity and mortality rate. Despite advances in critical care practices, sepsis remains the most common cause of death in intensive care units (ICUs). The objective of this study is to compare the mortality rate between severely septic and septic patients who used the ‘sepsis cocktail’, which contains hydrocortisone, vitamin C, thiamine, and fludrocortisone in both the ICU and the standard care group. The design of this study used an open-label randomized controlled trial. The data was collected in Law Phun hospital from May to June 2018 in relation to in-hospital mortality. There were 35 patients in both groups, with an average age of 63.0 ± 16.1 year and 60% were male. There were 17 subjects in the treatment group and 18 subjects in the control group, respectively. There were no significant differences in terms of baseline characteristics between the two groups except for lactate. The in-hospital mortality rate was significantly lower in the treatment group compared to the control group (11.8% vs. 44.4%, p=0.032). The median duration of length of stay was also a significant decrease in the intervention group compared to the control groups ([41.0 hours (26.1-76.7) vs. 96.0 (86.3-120.0), p=0.001)]. In conclusion, these results suggest that the adjunctive use of the sepsis cocktail and corticosteroid were effective in reducing the mortality and the length of stay of patients with severe sepsis and septic shock.

Downloads

Download data is not yet available.

References

General Affairs Division of Permanent [Internet]. Nonthaburi; Ministry of PublicHealth. 2018 [cited 20 November 2021] Available from: http://data.ptho.moph.go.th/inspec/2561.

Dellinger RP, Levy MM, Rhodes A, et al.Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637.

Guidelines for the treatment of severe sepsis and septic shock patients [Internet]. The Thai society of critical care medicine 2015. [cited 22 November 2021] Available from: http://www.ayhosp.go.th/ayh/ images/HA/miniconf/5.pdf.

Guidelines for clinical care for patients with sepsis and septic shock at Nakornping Hospital and Chiang Mai Provincial Public Health Network Hospital [Internet]. Nakornping Hospital, 2016 [cited 20 November 2021] Available from: http:// www.nkp-hospital.go.th/.

Marik PE, Varon J, Surani SR. Hydrocortisone, ascorbic acid and thiamine for sepsis: Is the jury out? World J Diabetes 2020;11:90-4.

Annane D, Renault A, Brun-Buisson C, et al. Hydrocortisone plus Fludrocortisone for adults with septic shock. N Engl J Med 2018;378:809-18.

Marik PE, Khangoora V, Rivera R, et al. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: A retrospective before-after study. Chest 2017;151:1229-38.

Beck V, Chateau D, Bryson GL, et al. Timing of vasopressor initiation and mortality in septic shock: a cohort study. Crit Care 2014;18:R97.

Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update. Intensive Care Med 2018;44:925-8.

Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993;328:1471-7.

Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008;358:111-24.

Gordon AC, Mason AJ, Thirunavukkarasu N, et al. effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized clinical trial. JAMA 2016;316:509-18.

Fowler III AA, Syed AA, Knowlson S, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med 2014;12:32.

May JM, Harrison FE. Role of vitamin C in the function of the vascular endothelium. Antioxid Redox Signal 2013;19:2068-83.

Wilson JX. Evaluation of vitamin C for adjuvant sepsis therapy. Antioxid Redox Signal 2013;19:2129-40.

Fisher BJ, Kraskauskas D, Martin EJ, et al. Attenuation of sepsis-induced organ injury in mice by vitamin C. JPEN J Parenter Enteral Nutr 2014;38:825-39.

Balakrishnan M, Gandhi H, Shah K, et al. Hydrocortisone, vitamin C and thiamine for the treatment of sepsis and septic shock following cardiac surgery. Indian J Anaesth 2018;62:934-9.

Kim SR, Ha YM, Kim YM, et al. Ascorbic acid reduces HMGB1 secretion in lipopolysaccharide-activated RAW 264.7 cells and improves survival rate in septic mice by activation of Nrf2/HO-1 signals. Biochem Pharmacol 2015;95:279-89.

Manning J, Mitchell B, Appadurai DA, et al. Vitamin C promotes maturation of T-cells. Antioxid Redox Signal 2013;19: 2054-67.

Bodwell JE, Holbrook NJ, Munck A. Sulfhydryl-modifying reagents reversibly inhibit binding of glucocorticoid-receptor complexes to DNA-cellulose. Biochemistry 1984;23:1392-8.

Okamoto K, Tanaka H, Ogawa H, et al. Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J Biol Chem 1999;274:10363-71.

Okamoto K, Tanaka H, Makino Y, et al. Restoration of the glucocorticoid receptor function by the phosphodiester compound of vitamins C and E, EPC-K1 (L-ascorbic acid 2-[3,4-dihydro-2,5,7,8- tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-yl hydrogen phosphate] potassium salt), via a redoxdependent mechanism. Biochem Pharmacol 1998;56:79-86.

Bürzle M, Hediger MA. Functional and physiological role of vitamin C transporters. Curr Top Membr 2012;70:357-75.

Fujita I, Hirano J, Itoh N, et al. Dexamethasone induces sodiumdependant vitamin C transporter in a mouse osteoblastic cell line MC3T3-E1. Br J Nutr 2001;86:145-9.

Marik PE, Pastores SM, Annane D, et al.Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008;36:1937-49.

Long CL, Maull KI, Krishnan RS, et al.Ascorbic acid dynamics in the seriously ill and injured. J Surg Res 2003;109:144-8.

Honore PM, Spapen HD, Marik P, et al. Dosing vitamin C in critically ill patients with special attention to renal replacement

therapy: a narrative review. Ann Intensive Care 2020;10:23.

Padayatty SJ, Sun H, Wang Y, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med 2004;140:533-7.

Seno T, Inoue N, Matsui K, et al. Functional expression of sodium-dependent vitamin C transporter 2 in human endothelial cells. J Vasc Res 2004;41:345-51.

Massey LK, Liebman M, Kynast-Gales SA. Ascorbate increases human oxaluria and kidney stone risk. J Nutr 2005;135:1673-7.

Sidhu H, Gupta R, Thind SK, et al. Oxalate metabolism in thiamine-deficient rats. Ann Nutr Metab 1987;31:354-61.

Donnino MW, Andersen LW, Chase M, et al. Randomized, double-blind, placebocontrolled trial of thiamine as a metabolic resuscitator in septic shock: A pilot study.Crit Care Med 2016;44:360-7.

Wandzilak TR, D’Andre SD, Davis PA, et al. Effect of high dose vitamin C on urinary oxalate levels. J Urol 1994;151:834-7.

Moskowitz A, Donnino MW. Thiamine (vitamin B1) in septic shock: A targeted therapy. J Thorac Dis 2020;12:S78-s83.

Downloads

Published

2022-08-31

Issue

Section

Original Article (บทความวิจัย)